Influenza B NP Antibodies

Santa Cruz Biotechnology offers a broad range of Influenza B NP Antibodies for the detection and analysis of the nucleoprotein (NP) of Influenza B virus. Influenza B NP Antibodies are validated for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The nucleoprotein plays an essential role in the viral life cycle by facilitating replication and transcription of viral RNA. Understanding Influenza B NP function advances the development of antiviral strategies and vaccines while providing insights into the pathogenesis of Influenza B virus infections. Influenza B NP monoclonal antibodies enable detailed examination of viral protein expression and localization in infected cells. Researchers can track viral infection progression and analyze host-pathogen interactions through multiple experimental approaches. Advanced visualization techniques using fluorescent conjugates allow for precise cellular localization studies. Extensive quality control ensures consistent performance across different experimental platforms. Santa Cruz Biotechnology monoclonal antibodies for Influenza B NP support vital research initiatives advancing our understanding of viral infections and potential therapeutic interventions.